Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Immunogenicity Study of the Covid-19 (Recombinante) Vaccine With a 4 or 8 Week Interval Between the First Doses.

  • Read more about Immunogenicity Study of the Covid-19 (Recombinante) Vaccine With a 4 or 8 Week Interval Between the First Doses.

Phase IIa Randomized Placebo Controlled Clinical Study of Codivir in Hospitalized Patients with Moderate COVID-19

  • Read more about Phase IIa Randomized Placebo Controlled Clinical Study of Codivir in Hospitalized Patients with Moderate COVID-19

COVID-19 Vaccination of Immunodeficient Persons (COVAXID)

  • Read more about COVID-19 Vaccination of Immunodeficient Persons (COVAXID)

Virological and Immunological Monitoring in Patients (suspected Of/confirmed With) COVID-19

  • Read more about Virological and Immunological Monitoring in Patients (suspected Of/confirmed With) COVID-19

Understanding Immunology and Patient Outcomes of COVID-19 in Hospitalized Patients

  • Read more about Understanding Immunology and Patient Outcomes of COVID-19 in Hospitalized Patients

Myocardial Injury and Dysfunction Associated With COVID-19 Vaccination

  • Read more about Myocardial Injury and Dysfunction Associated With COVID-19 Vaccination

Effectiveness of Using Interactive Consulting System to Enhance Decision Aids of COVID-19 Vaccination

  • Read more about Effectiveness of Using Interactive Consulting System to Enhance Decision Aids of COVID-19 Vaccination

Phase 2a Trial to Evaluate Safety and Immunogenicity of COVID-19 Vaccine Strategies in HIV-infected/Uninfected Adults.

  • Read more about Phase 2a Trial to Evaluate Safety and Immunogenicity of COVID-19 Vaccine Strategies in HIV-infected/Uninfected Adults.

Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19

  • Read more about Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19

A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination

  • Read more about A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 126
  • Page 127
  • Page 128
  • Page 129
  • Current page 130
  • Page 131
  • Page 132
  • Page 133
  • Page 134
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA